Quick Answer
CRESCENT BIOPHARMA, INC. reported Total Assets of $240.29 million for fiscal year 2025.
CRESCENT BIOPHARMA, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $240.29M | +574.7% |
| 2024 | $35.62M | -21.4% |
| 2023 | $45.32M | -12.5% |
| 2022 | $51.81M | -45.1% |
| 2021 | $94.35M | -33.9% |
| 2020 | $142.83M | -15.0% |
| 2019 | $167.97M | -21.8% |
| 2018 | $214.84M | +67.1% |
| 2017 | $128.58M | +203.3% |
| 2016 | $42.39M | -12.5% |
| 2015 | $48.46M | -15.4% |
| 2014 | $57.26M | +983.8% |
| 2013 | $5.28M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $138.27M | +780.8% | -12.2% |
| June 30, 2025 | $157.43M | +544.7% | +2527.3% |
| March 31, 2025 | $5.99M | -82.5% | -83.2% |
| December 31, 2024 | $35.62M | -21.4% | +126.9% |
| September 30, 2024 | $15.70M | -70.5% | -35.7% |
| June 30, 2024 | $24.42M | -60.5% | -28.6% |
| March 31, 2024 | $34.20M | -50.4% | -24.5% |
| December 31, 2023 | $45.32M | -12.5% | -14.8% |
- CRESCENT BIOPHARMA, INC. showed an increase of +574.7% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, CRESCENT BIOPHARMA, INC.’s total assets has grown by 4448.0% (from $5.28 million to $240.29 million).
- The most recent figure is from CRESCENT BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: